首页 | 本学科首页   官方微博 | 高级检索  
检索        


Guselkumab is superior to fumaric acid esters in patients with moderate-to-severe plaque psoriasis who are naive to systemic treatment: results from a randomized,active-comparator-controlled phase IIIb trial (POLARIS)
Authors:D Thaçi  A Pinter  M Sebastian  C Termeer  M Sticherling  S Gerdes  S Wegner  S Krampe  H Bartz  C Rausch  A Mensch  K Eyerich
Institution:1. Institute and Comprehensive Centre for Inflammation Medicine, University of Lübeck, Lübeck, Germany;2. Department of Dermatology, Venereology and Allergology, University Hospital of Frankfurt am Main, Frankfurt am Main, Germany;3. Dermatological Practice Dr. med. Michael Sebastian, Mahlow, Germany;4. Dermatological Practice Prof. Dr. med. Christian Termeer, Stuttgart, Germany

Department of Dermatology, University of Freiburg, Freiburg, Germany;5. Department of Dermatology, University Hospital of Erlangen, Erlangen, Germany;6. Psoriasis-Center, Department of Dermatology, Venerology and Allergology, University Hospital Schleswig-Holstein, Campus Kiel, Kiel, Germany;7. Janssen-Cilag GmbH, Neuss, Germany;8. Department of Dermatology and Allergy, Technical University of Munich, Munich, Germany

Abstract:
Keywords:
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号